MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-23-2026
Renalytix AI plc Operating Cash Flow 2011-2026 | RNLX
Annual Operating Cash Flow Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.1 M | -34.1 M | -45.9 M | -28.4 M | -9.52 M | -6.16 M | -427 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -427 K | -45.9 M | -22.1 M |
Quarterly Operating Cash Flow Renalytix AI plc
| 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.84 M | -22.3 M | -17.4 M | -9.5 M | - | -9.5 M | - | -25.5 M | -15.4 M | -7.12 M | -45.9 M | -31.8 M | -24.7 M | -10.5 M | -28.4 M | -23.3 M | -18.6 M | - | -9.52 M | - | - | - | -6.16 M | - | - | - | -427 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -427 K | -45.9 M | -17.2 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 206.18 | 0.82 % | $ 22.9 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 89.53 | -3.31 % | $ 4.19 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 4.63 | 2.88 % | $ 6.16 M | USA |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 21.44 | 1.68 % | $ 621 M | USA |
 |
Fulgent Genetics
FLGT
|
-102 M | $ 19.12 | 3.35 % | $ 588 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.04 B | $ 152.76 | 0.62 % | $ 12 B |  Irlanda |
 |
Guardant Health
GH
|
-185 M | $ 131.71 | 1.22 % | $ 16.5 B | USA |
 |
Illumina
ILMN
|
1.08 B | $ 165.78 | 3.59 % | $ 25.7 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 23.21 | 2.02 % | $ 1.24 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.74 | 3.57 % | $ 7.7 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-460 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 102.44 | 2.46 % | $ 6.91 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 193.18 | 1.68 % | $ 9.57 B | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.42 | 3.28 % | $ 426 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 475.39 | 1.84 % | $ 13.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 162.13 | -0.07 % | $ 24 B |  Schweiz |
 |
NeoGenomics
NEO
|
5.23 M | $ 11.74 | 2.62 % | $ 1.5 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.66 | 2.53 % | $ 432 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 20.98 | 6.23 % | $ 470 M | USA |
 |
Natera
NTRA
|
215 M | $ 222.41 | -0.19 % | $ 30.4 B | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 10.26 | 5.23 % | $ 916 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 7.65 | 2.9 % | $ 319 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 274.38 | 1.17 % | $ 22.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 492.63 | -0.34 % | $ 186 B | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.68 | 2.39 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 70.12 | 0.09 % | $ 4.19 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.32 | 0.38 % | $ 2.02 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |